To clarify my previous post, I did not mean to say that the treatment patients had an mPFS of 7.6 months. We know that that mPFS was confounded. I just meant to say that if they had not received DCax-L and had been selected in the same way as the placebos, they would have probably had an mPFS of about 7.6 months and would have ended up with a mOS well below 19 months.
Market Data 
Markets 
AI
